Aberrant TGF-β signaling has been observed in a preclinical prostate cancer model, in which the tumor suppressor PTEN is silenced specifically in the prostate, leading to premalignant alterations of the prostate epithelium. Here, TGFB1 is linked to Familial prostate cancer.